暴露于拉莫特里金的母乳养婴儿面临毒性影响的低风险
Ingrid Alvarez1,2, Katarina Tötterman3, Emma Honkaniemi4
1Division of Paediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
暴露于拉莫特里金的母乳养婴儿有毒效应的风险较低. 婴儿的母亲服用低剂量拉莫特里金的婴儿没有表现出任何症状,这表明简化后续可能是可能的.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
- 新生儿护理 新生儿护理
背景情况:
- 拉莫特里金是一种抗药,通常在怀孕期间处方.
- 已知lamotrigine的转移到母乳中,但婴儿暴露数据有限.
研究的目的:
- 为了评估母乳养婴儿的血拉莫特里金度.
- 通过母乳养对婴儿的拉莫特里金暴露的临床效果和安全性进行评估.
主要方法:
- 在瑞典斯德哥尔摩对47个母婴双进行了回顾性研究.
- 对婴儿血中拉莫特里金度的分析以及与母亲水平和剂量的相关性.
- 从医疗记录中收集的临床随访数据.
主要成果:
- 婴儿血中位数为2.5μmol/L,与母亲的度和剂量相关.
- 六名婴儿 (14%) 的度处于治疗范围之内;一名婴儿可能表现出与拉莫特里金相关的症状.
- 在21名婴儿中,有3名婴儿肝转氨酶水平升高. 孕产妇服用≤150毫克的婴儿的度无法检测,没有症状.
结论:
- 暴露于拉莫特里金的母乳养婴儿具有较低的副作用风险.
- 母亲服用低剂量兰特里金 (≤150毫克) 的婴儿血含量无法检测,没有症状.
- 一个简化后续协议可能适用于通过母乳养暴露于lamotrigine的低风险婴儿.
更多相关视频
09:02Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
09:12Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding
Published on: November 14, 2018
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Factors Affecting Drug Response: Overview
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
